EP0580094B1 - Blood collection assembly - Google Patents

Blood collection assembly Download PDF

Info

Publication number
EP0580094B1
EP0580094B1 EP19930111491 EP93111491A EP0580094B1 EP 0580094 B1 EP0580094 B1 EP 0580094B1 EP 19930111491 EP19930111491 EP 19930111491 EP 93111491 A EP93111491 A EP 93111491A EP 0580094 B1 EP0580094 B1 EP 0580094B1
Authority
EP
European Patent Office
Prior art keywords
tube
diamond
container
barrier
label
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
EP19930111491
Other languages
German (de)
French (fr)
Other versions
EP0580094A1 (en
Inventor
Mitchell K. Antoon, Jr.
Robert S. Golabek, Jr.
Nicholas A. Grippi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Becton Dickinson and Co
Original Assignee
Becton Dickinson and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Becton Dickinson and Co filed Critical Becton Dickinson and Co
Publication of EP0580094A1 publication Critical patent/EP0580094A1/en
Application granted granted Critical
Publication of EP0580094B1 publication Critical patent/EP0580094B1/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

Classifications

    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01LCHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L3/00Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
    • B01L3/50Containers for the purpose of retaining a material to be analysed, e.g. test tubes
    • B01L3/508Containers for the purpose of retaining a material to be analysed, e.g. test tubes rigid containers not provided for above
    • B01L3/5082Test tubes per se
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61JCONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00Containers specially adapted for medical or pharmaceutical purposes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61JCONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J2205/00General identification or selection means
    • A61J2205/10Bar codes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61JCONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J2205/00General identification or selection means
    • A61J2205/30Printed labels

Definitions

  • This invention relates to containers, especially evacuated blood collection tubes.
  • Such medical products that would derive a considerable benefit from improving their barrier properties include, but are not limited to, collection tubes and particularly those used for blood collection.
  • Blood collection tubes require certain performance standards to be acceptable for use in medical applications. Such performance standards include the ability to maintain greater than about 90% original draw volume over a one year period, to be radiation sterilizable and to be noninterfering in tests and analysis.
  • Draw volume retention depends on the existence of a partial vacuum, or reduced pressure, inside the tube. The draw volume changes in direct proportion to the change in vacuum (reduced pressure). Therefore, draw volume retention is dependent on good vacuum retention.
  • Radiation sterilizable means that after the tube is exposed to certain levels of radiation in the sterilization process, there is substantially no change in optical or mechanical and functional properties.
  • Noninterference in performance of a tube's specifications means that the materials of the tube, such as glass or plastic materials do not interfere with testing and analysis that is typically performed on blood in the tube. Such tests include but are not limited to, hematology, blood chemistry, blood typing, toxicology analysis and therapeutic drug monitoring. Furthermore, the tube must be capable of being subjected to automated machinery such as centrifuges.
  • US-A-4 809 876 describes a container for foods and beverages formed from a plastic resin and coated with a thin film of diamond-like carbon.
  • the diamond-like carbon film is applied either directly to an interior surface portion or to an exterior surface portion of the container.
  • the diamond-like carbon film reduces gas and vapor permeability of the container and may be formed by radio-frequency discharge, direct or dual ion beam deposition or sputtering.
  • the containers of US-A-4 809 876 are not suitable for use in the medical field.
  • a plastic container coated with a barrier label disposed over an outer surface of the plastic container improves the barrier properties of the plastic container, but does not obscure the contents of the plastic container and extends the shelf-life of plastic containers, especially plastic evacuated blood collection devices.
  • the barrier label comprises a diamond composition.
  • the diamond composition may be applied either to an interior surface portion or to an exterior surface portion of the label.
  • the barrier label may be placed or formed around the container and then adhered to the container by methods such as, but not limited to, an adhesive layer, heating the barrier label and container to a temperature sufficient to cause the barrier label to heat-shrink onto the container or by expanding the container into the barrier label by blow molding.
  • the diamond composition may provide a transparent, translucent or colorless appearance and may have printed matter applied thereon.
  • Plastic tubes with barrier labels coated with the diamond composition are able to maintain far better vacuum retention and draw volume retention than previous tubes comprised of polymer compositions and blends thereof without a barrier label.
  • the labeled tube's water barrier properties would be significantly improved since diamond coatings are substantially non-polar. Notably is the clarity of the diamond composition, its durability to substantially withstand resistance to impact, abrasion and scratches.
  • Suitable films to be coated for use as barrier labels according to the present invention include, but are not limited to polypropylene films, low and high density polyethylene films and polyvinylchloride films.
  • Printing may be placed on the barrier label which is to be used on the container of interest.
  • a product identification, bar code, brand name, company logo, lot number, expiration date and other data and information may all be included on the label surface.
  • a matte finish or a corona discharged surface may be developed on the outer surface of the barrier composition so as to make the surface appropriate for writing additional information on the label.
  • another pressure sensitive adhesive label may be placed over the outer surface of the barrier label so as to accommodate various hospital over-labels, for example.
  • FIGS. 1 and 2 show a typical blood collection tube 10, having an open end 16, a closed end 18 and stopper 14 which includes a lower annular portion or skirt 15 which extends into and presses against the inside walls 12 of the tube for maintaining stopper 14 in place.
  • FIG. 2 schematically illustrates that there are three mechanisms for a change in vacuum in a blood collection tube: (A) gas permeation through the stopper material; (B) gas permeation through the tube material and (C) leak at the closure-tube interface. Therefore, when there is substantially no gas permeation and no leak, there is good vacuum retention and good draw volume retention.
  • FIG. 3 shows the preferred embodiment of the invention, a plastic tube covered by a diamond coated barrier label.
  • the preferred embodiment includes many components which are substantially identical to the components of FIGS. 1 and 2. Accordingly, similar components performing similar functions will be numbered identically to those components of FIGS. 1 and 2, except that a suffix "a" will be used to identify those components in FIG. 3.
  • collection tube assembly 20 comprises a plastic tube 10a, having an open end 16a and a closed end 18a.
  • a coating comprising a diamond coated barrier label 25 extends over a substantial portion of the length of the tube which is upon the outer surface of the tube with the exception of open end 16a and closed end 18a thereof.
  • FIG. 4 illustrates an alternate embodiment of the invention, wherein collection tube assembly 40 comprises stopper 48 in place for closing open end 41 of tube 42.
  • stopper 48 includes an annular upper portion 50 which extends over the top edge of tube 42.
  • Stopper 48 includes a lower annular portion or skirt 49 which extends into and presses against the inside walls of tube 42 for maintaining stopper 48 in place and also, defines a well 52 which, in turn, defines a septum portion 53 for receiving a cannula therethrough.
  • the user once receiving a container such as that shown in FIG. 4 with a sample contained therein, may insert a cannula through septum 53 for receiving part or all of the contents in tube 42 to perform various tests on a sample.
  • FIG. 4 differs from the embodiment in FIG. 3 in that the tube may be evacuated with the simultaneous placement of stopper 48 therein after the application of a diamond coated barrier label 45 thereover the tube. Alternatively, the diamond coating or diamond coated barrier label may be applied to the tube before it has been evacuated.
  • An alternate embodiment of the invention also includes a label incorporating both the upper portion of the stopper, as well as the entire container tube. Such an embodiment may be utilized, for example, for sealing the container with the stopper in place. Once a sample has been placed in the tube, the sample cannot be tampered with by removal of the stopper. Additionally, serrations could be included at the tube, stopper interface. The serrations may be registered so that it can be determined if the sealed container has been tampered with.
  • tubes may contain reagents in the form of additives or coatings on the inner wall of the tube.
  • a coating comprising a diamond composition forms a clear or translucent barrier. Therefore, the contents of a plastic tube coated with a coating comprising a diamond composition are visable to the observer at the same time identifying information may be displayed over the diamond film after it is applied to the plastic tube.
  • a coating comprising a diamond composition may be formed on a substrate by radio frequency discharge, direct or dual ion beam deposition, sputtering or plasma chemical vapor deposition, as described in US-A-4,698,256, US-A-4,809,876, US-A-4,992,298 and US-A-5,005,318, the disclosures of which are herein incorporated by reference.
  • the coating of the present invention is a diamond composition comprising carbon having a major proportion of sp 3 tetrahedral bonding and a minor proportion of sp 2 bonds.
  • the diamond compositions of the present invention may consist of carbon atoms bonded in a dense chemical structure similar to that in a diamond, but without a long range crystal order.
  • the diamond coating is applied to a barrier film by a dual ion beam ballistic alloy process.
  • a plastic blood collection tube covered with a diamond coated barrier label may effectively be used in such applications as routine chemical analysis, biological inertness, hematology, blood chemistry, blood typing, toxicology analysis or therapeutic drug monitoring and other clinical tests involving body fluids.
  • the diamond coating may be hemorepellent and/or have characteristics of a clot activator.
  • plastic composite container is evacuated or not evacuated in accordance with this invention.
  • the presence of a barrier label on the outer surface of the container has the effect of maintaining the general integrity of the container holding a sample so that it may be properly disposed of without any contamination to the user. Notably is the clarity of the barrier label and their abrasion and scratch resistance.
  • the diamond coatings or blends thereof used in accordance with this disclosure may contain conventional additives and ingredients which do not adversely affect the properties of articles made therefrom.
  • the barrier label is a polymer film coated with a diamond composition.
  • Suitable film materials include polymeric substrate resins.
  • Polymeric substrate resins include, but are not limited to polyamide, polyolefin and polyester.
  • Polyamide includes but is not limited to, biaxial oriented nylon, aromatic amorphous polyamide, polyvinyl chloride and mixtures thereof.
  • Polyolefin includes, but is not limited to biaxial oriented polypropylene, low density polyethylene, polychlorotrifluoroethylene and mixtures thereof.
  • Polyester includes, but is not limited to, polyethylene terephthalate, polyethylene naphthalate, polyethylene isophthalate and mixtures thereof.

Description

  • This invention relates to containers, especially evacuated blood collection tubes.
  • With the increased emphasis on the use of plastic medical products, a special need exists for improving the barrier properties of articles made of polymers.
  • Such medical products that would derive a considerable benefit from improving their barrier properties include, but are not limited to, collection tubes and particularly those used for blood collection.
  • Blood collection tubes require certain performance standards to be acceptable for use in medical applications. Such performance standards include the ability to maintain greater than about 90% original draw volume over a one year period, to be radiation sterilizable and to be noninterfering in tests and analysis.
  • A critical performance standard of the blood collection tube is the draw volume retention. Draw volume retention depends on the existence of a partial vacuum, or reduced pressure, inside the tube. The draw volume changes in direct proportion to the change in vacuum (reduced pressure). Therefore, draw volume retention is dependent on good vacuum retention.
  • For example, it is important to maintain the vacuum over a period of time in order to provide appropriate storage life for those tubes prior to their being used. That is, it is important for the vacuum level to be maintained for a period of time prior to the time when a technician or a nurse uses the tube for collecting a blood sample.
  • Radiation sterilizable means that after the tube is exposed to certain levels of radiation in the sterilization process, there is substantially no change in optical or mechanical and functional properties.
  • Noninterference in performance of a tube's specifications means that the materials of the tube, such as glass or plastic materials do not interfere with testing and analysis that is typically performed on blood in the tube. Such tests include but are not limited to, hematology, blood chemistry, blood typing, toxicology analysis and therapeutic drug monitoring. Furthermore, the tube must be capable of being subjected to automated machinery such as centrifuges.
  • US-A-4 809 876 describes a container for foods and beverages formed from a plastic resin and coated with a thin film of diamond-like carbon. The diamond-like carbon film is applied either directly to an interior surface portion or to an exterior surface portion of the container. The diamond-like carbon film reduces gas and vapor permeability of the container and may be formed by radio-frequency discharge, direct or dual ion beam deposition or sputtering. However, the containers of US-A-4 809 876 are not suitable for use in the medical field.
  • It is the object of the present invention to provide a sample collecting container assembly suitable for use in the medical field.
  • This object is solved, according to the invention, with the features of the characterising part of claim 1.
  • With the present invention there is provided a plastic container coated with a barrier label disposed over an outer surface of the plastic container. The barrier label improves the barrier properties of the plastic container, but does not obscure the contents of the plastic container and extends the shelf-life of plastic containers, especially plastic evacuated blood collection devices. The barrier label comprises a diamond composition. The diamond composition may be applied either to an interior surface portion or to an exterior surface portion of the label.
  • The barrier label may be placed or formed around the container and then adhered to the container by methods such as, but not limited to, an adhesive layer, heating the barrier label and container to a temperature sufficient to cause the barrier label to heat-shrink onto the container or by expanding the container into the barrier label by blow molding.
  • The diamond composition may provide a transparent, translucent or colorless appearance and may have printed matter applied thereon.
  • Plastic tubes with barrier labels coated with the diamond composition are able to maintain far better vacuum retention and draw volume retention than previous tubes comprised of polymer compositions and blends thereof without a barrier label. In addition, the labeled tube's water barrier properties would be significantly improved since diamond coatings are substantially non-polar. Notably is the clarity of the diamond composition, its durability to substantially withstand resistance to impact, abrasion and scratches.
  • Suitable films to be coated for use as barrier labels according to the present invention include, but are not limited to polypropylene films, low and high density polyethylene films and polyvinylchloride films.
  • Printing may be placed on the barrier label which is to be used on the container of interest. For example, a product identification, bar code, brand name, company logo, lot number, expiration date and other data and information may all be included on the label surface. Moreover, a matte finish or a corona discharged surface may be developed on the outer surface of the barrier composition so as to make the surface appropriate for writing additional information on the label. Furthermore, another pressure sensitive adhesive label may be placed over the outer surface of the barrier label so as to accommodate various hospital over-labels, for example.
  • In the drawings:
    • FIG. 1 is a perspective view of a typical blood collection tube with a stopper.
    • FIG. 2 is a longitudinal sectional view of the tube of FIG. 1 taken along line 2-2.
    • FIG. 3 is a longitudinal sectional view of a tube-shaped container similar to the tube of FIG. 1 without a stopper.
    • FIG. 4 is a longitudinal sectional view of a tube-shaped container similar to the tube of FIG. 1 with a stopper.
  • Referring to the drawings in which like reference characters refer to like parts throughout the several views thereof, FIGS. 1 and 2 show a typical blood collection tube 10, having an open end 16, a closed end 18 and stopper 14 which includes a lower annular portion or skirt 15 which extends into and presses against the inside walls 12 of the tube for maintaining stopper 14 in place. FIG. 2 schematically illustrates that there are three mechanisms for a change in vacuum in a blood collection tube: (A) gas permeation through the stopper material; (B) gas permeation through the tube material and (C) leak at the closure-tube interface. Therefore, when there is substantially no gas permeation and no leak, there is good vacuum retention and good draw volume retention.
  • FIG. 3 shows the preferred embodiment of the invention, a plastic tube covered by a diamond coated barrier label. The preferred embodiment includes many components which are substantially identical to the components of FIGS. 1 and 2. Accordingly, similar components performing similar functions will be numbered identically to those components of FIGS. 1 and 2, except that a suffix "a" will be used to identify those components in FIG. 3.
  • Referring now to FIG. 3, the preferred embodiment of the invention, collection tube assembly 20 comprises a plastic tube 10a, having an open end 16a and a closed end 18a. A coating comprising a diamond coated barrier label 25 extends over a substantial portion of the length of the tube which is upon the outer surface of the tube with the exception of open end 16a and closed end 18a thereof.
  • FIG. 4 illustrates an alternate embodiment of the invention, wherein collection tube assembly 40 comprises stopper 48 in place for closing open end 41 of tube 42. As can be seen, stopper 48 includes an annular upper portion 50 which extends over the top edge of tube 42. Stopper 48 includes a lower annular portion or skirt 49 which extends into and presses against the inside walls of tube 42 for maintaining stopper 48 in place and also, defines a well 52 which, in turn, defines a septum portion 53 for receiving a cannula therethrough. Thus, the user, once receiving a container such as that shown in FIG. 4 with a sample contained therein, may insert a cannula through septum 53 for receiving part or all of the contents in tube 42 to perform various tests on a sample.
  • Covering a substantial portion of the length of the tube is a diamond coated barrier label 45. The barrier label 45 covers substantially most of the tube with the exception of open end 41 thereof. FIG. 4 differs from the embodiment in FIG. 3 in that the tube may be evacuated with the simultaneous placement of stopper 48 therein after the application of a diamond coated barrier label 45 thereover the tube. Alternatively, the diamond coating or diamond coated barrier label may be applied to the tube before it has been evacuated.
  • An alternate embodiment of the invention also includes a label incorporating both the upper portion of the stopper, as well as the entire container tube. Such an embodiment may be utilized, for example, for sealing the container with the stopper in place. Once a sample has been placed in the tube, the sample cannot be tampered with by removal of the stopper. Additionally, serrations could be included at the tube, stopper interface. The serrations may be registered so that it can be determined if the sealed container has been tampered with.
  • It will be understood by practitioners-in-the-art, such tubes may contain reagents in the form of additives or coatings on the inner wall of the tube.
  • A coating comprising a diamond composition forms a clear or translucent barrier. Therefore, the contents of a plastic tube coated with a coating comprising a diamond composition are visable to the observer at the same time identifying information may be displayed over the diamond film after it is applied to the plastic tube.
  • A coating comprising a diamond composition may be formed on a substrate by radio frequency discharge, direct or dual ion beam deposition, sputtering or plasma chemical vapor deposition, as described in US-A-4,698,256, US-A-4,809,876, US-A-4,992,298 and US-A-5,005,318, the disclosures of which are herein incorporated by reference.
  • The coating of the present invention is a diamond composition comprising carbon having a major proportion of sp3 tetrahedral bonding and a minor proportion of sp2 bonds. In general, the diamond compositions of the present invention may consist of carbon atoms bonded in a dense chemical structure similar to that in a diamond, but without a long range crystal order.
  • Desirably, the diamond coating is applied to a barrier film by a dual ion beam ballistic alloy process.
  • A plastic blood collection tube covered with a diamond coated barrier label may effectively be used in such applications as routine chemical analysis, biological inertness, hematology, blood chemistry, blood typing, toxicology analysis or therapeutic drug monitoring and other clinical tests involving body fluids.
  • If the inner surface of the plastic blood collection tube is also covered by a barrier label, the diamond coating may be hemorepellent and/or have characteristics of a clot activator.
  • It will be understood that it makes no difference whether the plastic composite container is evacuated or not evacuated in accordance with this invention. The presence of a barrier label on the outer surface of the container has the effect of maintaining the general integrity of the container holding a sample so that it may be properly disposed of without any contamination to the user. Notably is the clarity of the barrier label and their abrasion and scratch resistance.
  • The diamond coatings or blends thereof used in accordance with this disclosure, may contain conventional additives and ingredients which do not adversely affect the properties of articles made therefrom.
  • The barrier label is a polymer film coated with a diamond composition. Suitable film materials include polymeric substrate resins. Polymeric substrate resins include, but are not limited to polyamide, polyolefin and polyester. Polyamide includes but is not limited to, biaxial oriented nylon, aromatic amorphous polyamide, polyvinyl chloride and mixtures thereof. Polyolefin includes, but is not limited to biaxial oriented polypropylene, low density polyethylene, polychlorotrifluoroethylene and mixtures thereof. Polyester includes, but is not limited to, polyethylene terephthalate, polyethylene naphthalate, polyethylene isophthalate and mixtures thereof.

Claims (4)

  1. A sample collecting container assembly comprising a plastic container (10a) having an open end (16a), a closed end (18a), an inner surface (12a) and an outer surface, and a layer comprising a diamond-based composition, characterised by a barrier label (25) comprising a polymer film coated with the layer comprising the diamond-based composition, the barrier label (25) being mounted on the outer surface of said plastic container (10a) and extending over a major portion of said outer surface of said plastic container (10a).
  2. The assembly of claim 1, wherein said polymer film of said barrier label (25) comprises material selected from the group consisting of polyamide, polyolefin and polyester.
  3. The assembly of claim 1 or 2, wherein said layer comprising the diamond-based composition is deposited by radio-frequency discharge, dual ion beam deposition, direct ion beam deposition, sputtering or plasma chemical deposition.
  4. The assembly of one of claims 1-3 wherein said barrier label (25) incorporates both, the upper portion of a stopper (48) within the open end (16a) of the plastic container (10a) as well as the entire plastic container (10a).
EP19930111491 1992-07-22 1993-07-17 Blood collection assembly Expired - Lifetime EP0580094B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US91886492A 1992-07-22 1992-07-22
US918864 1992-07-22

Publications (2)

Publication Number Publication Date
EP0580094A1 EP0580094A1 (en) 1994-01-26
EP0580094B1 true EP0580094B1 (en) 1996-10-16

Family

ID=25441088

Family Applications (1)

Application Number Title Priority Date Filing Date
EP19930111491 Expired - Lifetime EP0580094B1 (en) 1992-07-22 1993-07-17 Blood collection assembly

Country Status (6)

Country Link
EP (1) EP0580094B1 (en)
JP (1) JP2504915B2 (en)
AU (1) AU664287B2 (en)
CA (1) CA2100275A1 (en)
DE (1) DE69305443T2 (en)
ES (1) ES2093331T3 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6979307B2 (en) 1997-06-24 2005-12-27 Cascade Medical Enterprises Llc Systems and methods for preparing autologous fibrin glue
US7745106B2 (en) 1997-06-24 2010-06-29 Cascade Medical Enterprises, Llc Methods and devices for separating liquid components

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2110761A1 (en) * 1992-12-18 1994-06-19 Yelena G. Tropsha Barrier label
US5871700A (en) * 1993-12-21 1999-02-16 C.A. Greiner & Sohne Gesellschaft M.B.H. Holding device with a cylindrical container and blood sampling tube with such a holding device
AT402365B (en) * 1993-12-21 1997-04-25 Greiner & Soehne C A RECEIVER WITH A CYLINDRICAL CONTAINER AND BLOOD SAMPLING TUBE WITH SUCH A RECEIVER
GB9405029D0 (en) * 1994-03-15 1994-04-27 Franks Joseph Dr Improved catheters and other tubular inserts
JPH0853116A (en) * 1994-08-11 1996-02-27 Kirin Brewery Co Ltd Plastic container coated with carbon film
GB9709071D0 (en) * 1997-05-02 1997-06-25 Howmedica A process for improving start up and steady rate friction of soft/compliant polyurethanes
US6179787B1 (en) * 1997-09-12 2001-01-30 Becton Dickinson And Company Collection container assembly
CA2450639C (en) * 2001-06-18 2012-03-20 Becton, Dickinson And Company Multilayer containers and process for forming multilayer containers
DK2251453T3 (en) 2009-05-13 2014-07-07 Sio2 Medical Products Inc container Holder
US7985188B2 (en) 2009-05-13 2011-07-26 Cv Holdings Llc Vessel, coating, inspection and processing apparatus
US9458536B2 (en) 2009-07-02 2016-10-04 Sio2 Medical Products, Inc. PECVD coating methods for capped syringes, cartridges and other articles
US11624115B2 (en) 2010-05-12 2023-04-11 Sio2 Medical Products, Inc. Syringe with PECVD lubrication
US9878101B2 (en) 2010-11-12 2018-01-30 Sio2 Medical Products, Inc. Cyclic olefin polymer vessels and vessel coating methods
US9272095B2 (en) 2011-04-01 2016-03-01 Sio2 Medical Products, Inc. Vessels, contact surfaces, and coating and inspection apparatus and methods
AU2012318242A1 (en) 2011-11-11 2013-05-30 Sio2 Medical Products, Inc. Passivation, pH protective or lubricity coating for pharmaceutical package, coating process and apparatus
US11116695B2 (en) 2011-11-11 2021-09-14 Sio2 Medical Products, Inc. Blood sample collection tube
EP2846755A1 (en) 2012-05-09 2015-03-18 SiO2 Medical Products, Inc. Saccharide protective coating for pharmaceutical package
JP6509734B2 (en) 2012-11-01 2019-05-08 エスアイオーツー・メディカル・プロダクツ・インコーポレイテッド Film inspection method
EP2920567B1 (en) 2012-11-16 2020-08-19 SiO2 Medical Products, Inc. Method and apparatus for detecting rapid barrier coating integrity characteristics
US9764093B2 (en) 2012-11-30 2017-09-19 Sio2 Medical Products, Inc. Controlling the uniformity of PECVD deposition
WO2014085346A1 (en) 2012-11-30 2014-06-05 Sio2 Medical Products, Inc. Hollow body with inside coating
US20160015898A1 (en) 2013-03-01 2016-01-21 Sio2 Medical Products, Inc. Plasma or cvd pre-treatment for lubricated pharmaceutical package, coating process and apparatus
CN110074968B (en) 2013-03-11 2021-12-21 Sio2医药产品公司 Coated packaging material
US9937099B2 (en) 2013-03-11 2018-04-10 Sio2 Medical Products, Inc. Trilayer coated pharmaceutical packaging with low oxygen transmission rate
EP2971227B1 (en) 2013-03-15 2017-11-15 Si02 Medical Products, Inc. Coating method.
EP3693493A1 (en) 2014-03-28 2020-08-12 SiO2 Medical Products, Inc. Antistatic coatings for plastic vessels
JP2018523538A (en) 2015-08-18 2018-08-23 エスアイオーツー・メディカル・プロダクツ・インコーポレイテッド Drug packaging and other packaging with low oxygen transmission rate

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4164320A (en) * 1974-09-26 1979-08-14 Medical Laboratory Automation, Inc. Patient and specimen identification means and system employing same
US4783361A (en) * 1984-09-10 1988-11-08 Ovonic Synthetic Materials Company, Inc. Coated lenses
US5019243A (en) * 1987-04-03 1991-05-28 Mcewen James A Apparatus for collecting blood
US4809876A (en) * 1987-08-27 1989-03-07 Aluminum Company Of America Container body having improved gas barrier properties
US5173266A (en) * 1989-07-19 1992-12-22 Drummond Scientific Company Safety pipet

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6979307B2 (en) 1997-06-24 2005-12-27 Cascade Medical Enterprises Llc Systems and methods for preparing autologous fibrin glue
US7745106B2 (en) 1997-06-24 2010-06-29 Cascade Medical Enterprises, Llc Methods and devices for separating liquid components
US8491564B2 (en) 1997-06-24 2013-07-23 Cascade Medical Enterprises, Llc Systems and methods for preparing autologous fibrin glue
US8802362B2 (en) 2002-01-15 2014-08-12 Cascade Medical Enterprises, Llc Methods and devices for separating liquid components

Also Published As

Publication number Publication date
EP0580094A1 (en) 1994-01-26
CA2100275A1 (en) 1994-01-23
DE69305443D1 (en) 1996-11-21
JPH06165772A (en) 1994-06-14
JP2504915B2 (en) 1996-06-05
AU664287B2 (en) 1995-11-09
AU4197893A (en) 1994-01-27
DE69305443T2 (en) 1997-03-06
ES2093331T3 (en) 1996-12-16

Similar Documents

Publication Publication Date Title
EP0580094B1 (en) Blood collection assembly
EP0571116A1 (en) Blood collection tube assembly
EP0603717B1 (en) Barrier label
AU669754B2 (en) Barrier coating
US5716683A (en) Blood collection tube assembly
EP0789092B1 (en) Blood collection tube assembly
US5955161A (en) Blood collection tube assembly
KR920000734B1 (en) A tube for taking samples of blood
AU681530B2 (en) Container and related sample collection tube
EP0787824B1 (en) Container with a non-ideal barrier coating sequence composition
EP0535810A1 (en) Blood collection tube assembly
AU7936601A (en) Medical article having blood-contacting surface
EP0300221A2 (en) Body fluid sample collection tube composite
EP0787825A1 (en) Blood collection tube assembly
US5160329A (en) Biological fluid specimen collection bag
EP0295416A1 (en) Body fluid sample collection tube composite
JPH0377541A (en) Liquid-sampling vessel
CA2179231A1 (en) Barrier coating
JPH0316134B2 (en)
JPH1014905A (en) Sample assembly
CA2271504A1 (en) Blood collection tube assembly
AU3130201A (en) Assembly for collecting blood or other body fluids

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): BE DE ES FR GB IT SE

17P Request for examination filed

Effective date: 19940305

17Q First examination report despatched

Effective date: 19950518

GRAG Despatch of communication of intention to grant

Free format text: ORIGINAL CODE: EPIDOS AGRA

GRAH Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOS IGRA

GRAH Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOS IGRA

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): BE DE ES FR GB IT SE

ET Fr: translation filed
REF Corresponds to:

Ref document number: 69305443

Country of ref document: DE

Date of ref document: 19961121

REG Reference to a national code

Ref country code: ES

Ref legal event code: FG2A

Ref document number: 2093331

Country of ref document: ES

Kind code of ref document: T3

ITF It: translation for a ep patent filed

Owner name: ING. C. GREGORJ S.P.A.

PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

26N No opposition filed
PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: ES

Payment date: 19980720

Year of fee payment: 6

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: SE

Payment date: 19990707

Year of fee payment: 7

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: ES

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 19990718

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: BE

Payment date: 19990915

Year of fee payment: 7

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20000718

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: BE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20000731

BERE Be: lapsed

Owner name: BECTON DICKINSON AND CY

Effective date: 20000731

EUG Se: european patent has lapsed

Ref document number: 93111491.2

REG Reference to a national code

Ref country code: GB

Ref legal event code: IF02

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: GB

Payment date: 20030709

Year of fee payment: 11

REG Reference to a national code

Ref country code: ES

Ref legal event code: FD2A

Effective date: 20000810

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: GB

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20040717

GBPC Gb: european patent ceased through non-payment of renewal fee

Effective date: 20040717

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IT

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES;WARNING: LAPSES OF ITALIAN PATENTS WITH EFFECTIVE DATE BEFORE 2007 MAY HAVE OCCURRED AT ANY TIME BEFORE 2007. THE CORRECT EFFECTIVE DATE MAY BE DIFFERENT FROM THE ONE RECORDED.

Effective date: 20050717

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: FR

Payment date: 20050718

Year of fee payment: 13

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: DE

Payment date: 20050831

Year of fee payment: 13

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: DE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20070201

REG Reference to a national code

Ref country code: FR

Ref legal event code: ST

Effective date: 20070330

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: FR

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20060731